Oct 5 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N :
* Johnson & Johnson Diabetes Care Companies - Animas corp intends to discontinue manufacturing, sale of animas vibe and onetouch ping insulin pumps
* Johnson & Johnson Diabetes Care Companies - Animas corp also intends to close operations and exit insulin pump business
* Johnson & Johnson Diabetes Care Companies - Animas selected Medtronic (NYSE:MDT) as partner to facilitate transition for patients, caregivers, healthcare providers
* Johnson & Johnson Diabetes Care Companies - patients using an Animas insulin pump will be offered option to transfer to a Medtronic pump
* Johnson & Johnson Diabetes Care Companies - Johnson & Johnson is continuing to evaluate potential strategic options for Lifescan Inc
* Johnson & Johnson Diabetes Care Companies - for patients, healthcare providers outside of U.S., Canada Animas to continue to sell pumps, operate as usual